Florida Society of Clinical Oncology: Florida Society of Clinical Oncology: The Voice of Oncology in FloridaThe Voice of Oncology in Florida
FLASCOFLASCO
2017 2017 –– 2018 2018 LeadershipLeadership
Richard McDonough MD
President
Luis Raez MD
Vice President
Barry Berman MD
Secretary
Hank Hill MD
Treasurer
Michael Diaz MD
Immediate Past President
Syed Abid MD Al-Hazzouri MD
Sikander Ailawadhi MD Gary Bowers MD
Delmarie Butler RN CBHN BSHSA CNBNN
Robert Cassell MD PhD Melody Chang RPh
Chakra Chaulagain MD FACP Gerardo Colon-Otero MD
Jose Davila MD Mary Dean MD
Aaron Denson MD Craig Deligdish MD
Dina Dumercy PharmD BCOP Ana Espinosa DNP MBA RN OCN
Steven Fein MD Karen Fields MD
Laura Freedman MD Jorge J. Garcia PharmD
Thomas George MD FACP Shelly Glenn
Terry Gruchow PAC Lucio Gordan MD
Ardeshir Hakam MD William Harrer MD
Eric Harris DO Randal Henderson MD MBA
John Hiemenz MD Maen Hussein MD
Mohammad Jahanzeb MD Kun Jiang MD
Sachin Kamath MD Waseem Khan MD Jeanelle King PAC
Kapisthalam Kumar MD Richard Levine MD
Mayra Lima MSN ARNP FNPC Loretta Loftus MD MBA
Shannon Luker RN OCN CBCN Reshma Mahtani DO
Merry Jennifer Markham MD Alan Marks MD
Shahla Masood MD Tarek Mekhail MD
Joseph Mignone MD Arjun Mittra MD MBBS
Daniel Morris MD Pareshkumar Patel MD
Brendan Prendergast MD Luis Raez MD
Brian Ramnaraign MD Joseph Rosenblatt MD Edgardo Santos MD
Shalin Shah DO Jason Starr DO
Winston Tan MD Scott Tetreault MD Beau Toskich MD
Gene Wetzstein, PharmD, BCOP, CPh Teri Valls
Magali Van den Bergh MD
Jonathan Zager, MD
Dorothy Phillips Executive Director
C ourse Description: The Florida Society of Clinical Oncology is hosting a two day meeting designed for medical oncologists, hematologists, radiation
oncologists, surgical oncology, pathologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents, and fellows that manage heath care for cancer patients. This conference will provide an emphasis on multidisciplinary collaboration among all professional health care teams with dynamic educational tracks that focus on specific driven topics addressing the current and future changes in the landscape of cancer care.
The 2017 Fall meeting will center on the multi-disciplinary presentations and case studies in AML, Myeloma, and CNS which include the collaboration of top clinicians, as well as up-to-date information on Healthcare Disparities. Additional sessions include information on hot topics in nursing, patient navigation, pharmacy, and administration.
FLASCO 2017 FALL SESSION October 20-21, 2017
Renaissance Orlando at Sea World 6677 Harbor Drive │ Orlando, Florida 32821
FLASCO 40th
ANNIVERSARY CELEBRATION
Join us Friday evening to help us
celebrate 40 years of FLASCO
history from the perspective of
Oncology Advancements, featuring
ASCO CEO, Dr. Clifford Hudis
and many Past FLASCO
Presidents!
FLASCO Fall Session Features Four Educational Tracks
Multi-
Disciplinary Pharmacy Administrator
Nursing/
Navigator
“Oncology Disparities”
Key Note Speaker:
Harold P. Freeman, MD President and CEO Harold P. Freeman Patient Navigation Institute New York City, New York
Friday, October 20, 2017
4:30–6:00pm Poster Presentations ~ View the latest research efforts
6:00–7:30 pm Reception/Visit Exhibits/Cash Bar Available
7:30–9:30 pm Dinner & Program ~ Celebrate FLASCO 40th Anniversary
Moderator: Dorothy Phillips, Executive Director, FLASCO
40 Years of Advances in Cancer Care—Clifford Hudis, MD, ASCO CEO
Saturday, October 21, 2017
6:30-8:00am Registration/Breakfast/Visit Exhibitors
8:00–8:30am Opening Remarks & Supporter Recognition
Edgardo Santos, MD, FACP, FLASCO Program Chairman, Boca Raton Regional Hospital
8:30–9:30am Oncology Disparity ~ Moderator: Luis Raez, MD, Memorial Healthcare System
Harold P. Freeman, MD, President and CEO, Harold P. Freeman Patient Navigation Institute, New York
9:30–10:15am Break/Visit Exhibitors
10:15–
11:45am
Multi-Disciplinary Pharmacy Nursing/ Navigator Administrator
AML MODERATOR
Denise Pereira, MD University of Miami
ACADEMIC ONCOLOGY Julio Hajdenberg, MD, FACP UF at Orlando Health
CASE STUDY (AML) Daniel Kerr, MD, PhD Moffitt Cancer Center
Multiple Myeloma
ACADEMIC ONCOLOGY Sikander Ailawadhi, MD Mayo Clinic Florida
CASE STUDY (Multiple Myeloma) Abdullah Khan, MD University of Florida
PANEL
BONE MARROW TRANSPLANT Hugo F. Fernandez, MD Moffitt Cancer Center
COMMUNITY ONCOLOGY Steven Fein, MD Miami Cancer Institute
HEMATOLOGY PATHOLOGY Elizabeth Sagatys, MD Moffitt Cancer Center
Clinical Considerations of Herbal Product
Utilization within the Oncology Patient
Population
Jessica Unzaga, PharmD, BCPS Memorial Healthcare System
Ashwin Mehta, MD
Memorial Healthcare System
Breast Cancer Case Studies
MODERATORS
Ana Espinosa, DNP, MBA, RN, OCN Memorial Cancer Institute
Mayra Lima, MSN, ARNP, FNP-C University of Miami
BREAST NAVIGATOR Cara Kondaki, MSW Cleveland Clinic
PHARMACIST Katerine Dumais, PharmD, MPH Memorial Cancer Institute
NURSE PRACTITIONER Deborah Hawkins, ARNP Florida Cancer Specialists
REHABILITATION PHYSICIAN Amber Searcy, DPT, CLT Good Samaritan Medical
SOCIAL WORKER Victoria Petersen, LCSW Moffitt Cancer Center
CLINICAL RESEARCH NURSE Cheryl Habaue,MSN, RN, CCRP Memorial Healthcare System
NUTRITIONIST Amanda Amigo, RDN, CSR, LD/N Cleveland Clinic Florida
GENETICS NURSE PRACTITIONER Sara Carroll, MS, CGC Cleveland Clinic Florida
10:15-11:00 AM
Multi-Faceted Oncology Management
Kevin Mays, EdD Mays Leadership Group
**************
11:00-11:45 AM
Discussion Panel PRIVATE PRACTICE
Shelli Johnson Cancer Care Centers of Brevard
LARGE PRACTICE Inga Gonzalez Florida Cancer Specialists
HOSPITAL BASED Maggie Wiegandt Memorial Healthcare System
ACADEMIC CENTER Josh Mattson Mayo Clinic Florida
MODERATOR Gail Erentreich Cancer Care Centers of Brevard
11:45–12:45pm Lunch/Networking
12:45 –
2:15pm
Multi-Disciplinary Pharmacy Nursing/ Navigator Administrators
CNS MODERATOR
Eric Harris, DO Florida Cancer Specialists
NEURO-ONCOLOGY Herbert Newton, MD Florida Hospital
NEURO-SURGERY Ronald Reimer, MD Mayo Clinic Florida
NEURO-RADIOLOGY Vivek Gupta, MD Mayo Clinic Florida
RADIATION-ONCOLOGY Naren Ramakrishna, MD, PhD Orlando Health
NEURO-PATHOLOGY Robert Macaulay, MD Moffitt Cancer Center
CASE STUDY Sonikpreet, MD Mayo Florida Fellow
12:45PM - 1:45PM The Immune System
Strikes Back; Revenge of the T-cell: The Saga of
Chimeric Antigen Receptor T-Cell Therapy
Christina Bachmeier, PharmD, BCOP Moffitt Cancer Center
**********
2:00PM - 3:00PM Going Beyond the Standard of Care:
Translation of Personalized Medicine
into the Clinical Oncology Setting
Christine M. Walko, PharmD, BCOP Moffitt Cancer Center
MODERATOR Shannon Luker, RN, OCN, CBCN Parrish Medical Center
12:45PM - 1:45PM
Precision Medicine and Molecular Testing
David Sallman, MD Moffitt Cancer Center
**********
2:00PM - 3:00PM
Cancer Diagnosis and Financial Toxicity
Elaine Towle, CMPE American Society of Clinical Oncology (ASCO)
Transition to Integrating Value-Based Care into
Fee-For-Service
NAVIGATION Carolina Figueredo, RN Memorial Healthcare System
SURVIVORSHIP TBD
COORDINATION OF CARE Beth Wittmer Florida Cancer Specialists
WORKFLOW QUALITY MEASURES Sierra Tomlinson Florida Cancer Specialists
MODERATOR Maggie Wiegandt, MBA Memorial Healthcare System
2:15 – 3:00 pm Interventional Oncology
Beau Toskich, MD Mayo Clinic Florida
3:00 pm Closing Remarks
Upon completion of the conference you will be able to:
1. Discuss new treatment options of multiple myeloma, AML, and CNS giving the different
perspectives of multi-disciplinary physicians.
2. Learn the new technology of interventional oncology.
3. Explain the importance of CAR-T, the benefits of herbal product utilization, and what
personalized medicine means to the clinical oncology setting.
4. Share the different perspectives of treatment and care of breast cancer case studies from
the expertise of many oncology professionals.
5. Learn organizational skills from a professional Oncology Management Coach.
CONFERENCE OBJECTIVES
Page 3 of 4Page 3 of 4 FLASCO CONFERENCE GOAL FLASCO CONFERENCE GOAL is to continue to develop a comprehensive
range of programs that emphasize the latest developments, state-of-the-art information
and enhanced educational strategies for the intra-professional team.
CONFERENCE OUTCOME MEASURES:CONFERENCE OUTCOME MEASURES:
Participants should be able to apply the knowledge acquired during this Participants should be able to apply the knowledge acquired during this
conference to improve their competence, performance, and/or patient outcomes conference to improve their competence, performance, and/or patient outcomes
in the daily treatment of their patients. To measure attendees perceptions of in the daily treatment of their patients. To measure attendees perceptions of
these gains, they will complete an evaluation form at the end of the conference.these gains, they will complete an evaluation form at the end of the conference.
ACCREDITATION STATEMENTS Physicians: The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
FLASCO has applied to the Medical Educator Consortium to approve this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical Educator Consortium and Florida Society of Clinical Oncology. The Medical Educator Consortium is accredited by the ACCME to provide continuing medical education for physicians.
Disclosure Statement:
The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.
Nurses and Patient Navigators: Approval for nurses to receive CE has been applied for to the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996, to award up to 6.0 continuing education contact hours through the Florida Board of Nursing. FLASCO maintains responsibility for this program.
Pharmacists: This program is not yet approved for CME credit. CME credit has been applied for from Memorial Hospital. Total number of approved credits is yet to be determined. FLASCO maintains responsibility for this program.
This conference is proudly co-sponsored by the
following companies:
2017 Corporate Members As of 6/27/2017
Diamond Elite Alexion Amgen Bristol-Myers Squibb Celgene Genentech BioOncology Merck Takeda Oncology Teva Pharmaceuticals
Diamond Astellas AstraZeneca Bayer Oncology Boehringer Ingelheim EMD Serono Lilly Oncology Pfizer Biosimilars Pfizer Oncology Sanofi Genzyme
Platinum AbbVie Adaptive Biotechnologies Biodesix Counsyl Eisai Exelixis Foundation Medicine Guardant Health Incyte INSYS Therapeutics J & J HealthCare Systems Kite Pharma Medivation Field Solutions Myriad Genetics NanoString Technologies Oncology Supply/ION Solutions Pharmacyclics Sandoz Seattle Genetics Taiho Oncology, Inc. Walgreens
Gold Biotheranostics Gilead Sciences IPSEN Biopharmaceuticals Merrimack Pharmaceuticals Novartis Oncology
Silver Clovis Oncology enterade® Helsinn Heron Therapeutics Invitae Kroger Specialty Pharmacy Lexicon Pharmaceuticals Novocure Spectrum TESARO
FLASCO acknowledges the following companies as FLASCO Corporate Members
Page 4 of 4Page 4 of 4
Before or on Sept. 15, 2017 After Sept. 15, 2017
FLASCO Regular Members Complimentary $50.00
FLASCO Affiliate Members Complimentary $50.00
FLASCO Associate Members Complimentary $50.00
FLASCO Courtesy Members $100.00 $150.00
Non-FLASCO Members $250.00 $300.00
Registration is complimentary prior to September 15, 2017 for FLASCO Regular, Affiliate and Associate Members.
Reminder: To keep your complimentary membership active and in good standing, FLASCO members are encouraged to participate in at least one FLASCO or FLASCO co-sponsored event prior to December 31, 2018, or make a minimum contribution of $50 to FLASCO.
FLORIDA SOCIETY OF CLINICAL ONCOLOGY 10022 Water Works Lane │ Riverview, FL │ 33578 Phone: 813.677.0246 ext. 102 │ Fax: 813.677.0559
Email: [email protected]
FLASCO reserves the right to alter this program without prior notice. Speakers and agenda are subject to change.
A block of rooms has been reserved at the
Renaissance Orlando at SeaWorld Hotel
6677 Sea Harbor Drive │ Orlando, Florida 32821
Reservations can be made by calling (407) 351-5555
Or clicking here. Please contact the hotel directly if room
arrangements are needed and mention your attendance to the
FLASCO Fall Session to receive the discounted rate of $169
plus applicable fees and taxes.
DEADLINES - The Renaissance Hotel has requested that all reservations be made
prior to September 15, 2017. After that date, reservations will only be accepted on
a space available and rate available basis.
HOTEL RESERVATIONS
The Florida Society of Clinical Oncology is a statewide non-profit
organization committed to facilitating and promoting multidisciplinary
efforts to improve patient care in Florida by:
Fostering access to quality cancer care to the citizens of Florida.
Assisting the cancer practitioners in providing the most cost effective quality care for
their patients.
Acting as an advocate for Florida cancer patients and their families.
Coordinating the dissemination of information and providing an opportunity for
oncologists, physicians, and other health care professionals to network and exchange
information on cancer care.
REGISTRATION & FEESREGISTRATION & FEES
FLASCO MISSION STATEMENT